Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma.

Trial Profile

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2011

At a glance

  • Drugs Carboplatin (Primary) ; Thalidomide (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jun 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 22 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top